Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study-Reference-Cited by-同舟云学术

Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study

Published:2017-04 Issue:2 Volume:66 Page:317-325
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Hide Michihiro,Yagami Akiko,Togawa Michinori,Saito Akihiro,Furue Masutaka

Funder

Taiho Pharmaceutical, Tokyo, Japan

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference24 articles.

1. Urticaria guidelines: consensus and controversies in the European and American guidelines;Fine;Curr Allergy Asthma Rep,2015

2. Epidemiology of urticaria: a representative cross-sectional population survey;Zuberbier;Clin Exp Dermatol,2010

3. Epidemiology of urticaria in Spain;Gaig;J Investig Allergol Clin Immunol,2004

4. Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries;Hide;Allergol Int,2012

5. BSACI guidelines for the management of chronic urticaria and angio-oedema;Powell;Clin Exp Allergy,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial;European Journal of Pharmaceutical Sciences;2024-12

2. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

3. Exploring the safety profile of bilastine in chronic spontaneous urticaria: A real-world analysis in the Indian population;Indian Journal of Dermatology, Venereology and Leprology;2024-07-11

4. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

5. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10